Sonoma Keeps You Informed

Sign up for email alerts to receive Sonoma updates including press releases, filings and special announcements straight to your inbox.

Sign me up for:

Upcoming Events

2021 Annual Meeting of Stockholders

Sep 15, 2021 • 2:00pm MDT

View All Events

Latest Financial Results

FY 2021

Fiscal Year Ended Mar 31, 2021

Latest Annual Filing

Fiscal Year Ended Mar 31, 2021

View Filing

Stock Information

Company Overview

Sonoma Pharmaceuticals, Inc., develops and produces stabilized hypochlorous acid (HOCl) products for various applications, including wound care, animal health care, eye care, oral care, and dermatological conditions. The company's products, which are sold throughout the world, have improved outcomes for more than ten million patients globally by reducing infection, itch, pain, scarring and harmful inflammatory responses. Sonoma’s headquarters are in Woodstock, Georgia, with manufacturing operations in Jalisco, Mexico. European marketing and sales are headquartered in Roermond, Netherlands.
Sonoma Investor Presentation March 2021

Sonoma Investor Presentation March 2021

Download Sonoma Investor Presentation March 2021

Leadership

Having accumulated decades of collective experience across a variety of fields, our leadership team is the source of our success.

Investor Contact Information

Company

Sonoma Pharmaceuticals, Inc.
645 Molly Lane
Suite 150
Woodstock, GA 30189

Investor Relations

T: 470-938-1011
ir@sonomapharma.com

Transfer Agent

Computershare
462 South 4th Street
Suite 1600
Louisville, KY 40202
T: 888-647-8901